摘要
背景:香豆素是多酚化合物,经常用于治疗补充和替代药物中的炎症。目的:在本研究中,我们回顾了体内和体外实验模型研究香豆素潜在抗炎特性的方法。 方法:对2005年1月1日至2015年12月31日期间的PUBMED,MEDLINE,Web of Science和Scopus进行文献检索。检索的关键词是“消炎”和“香豆素”和“体内”或“体外”。该搜索确定了425篇文章标题。 结果:在425篇文章标题中,127篇全文文章被评审,其中69篇被纳入分析。大部分研究(81.2%)用于体外测定。研究主要集中在肿瘤坏死因子(TNF),白细胞介素(IL)-6和IL-1-β(55.1%)等细胞因子以及水肿(46.5%),一氧化氮(NO,23.2% ,氧化应激(21.7%),炎症细胞(21.7%),核因子(NF)-κB(24.6%),丝裂原活化蛋白激酶(MAPK,13%),髓过氧化物酶(MPO,15.9% )-2(14.5%),前列腺素E2(PGE2 8.7%),5-脂氧合酶(LOX 4.3%)和粘附分子7.2%,香豆素抑制所有这些参数,除了IL-10,核因子红细胞2 (NFE2)相关因子2(Nrf2)和调节性T细胞(Treg)分化。 结论:体外法是最常用于研究香豆素类抗炎作用的方法。结果表明,香豆素通过抑制NF-κB,活化T细胞核因子(NFAT),视黄酸相关孤儿受体γτ(RORγτ)和MAPK以及增加Nrf2激活来发挥抗炎和抗氧化活性。这些结果表明香豆素可能是开发新型抗炎治疗药物的重要候选物。
关键词: 抗炎作用,香豆素,体内,体外,水肿,介质,转录因子。
Current Medicinal Chemistry
Title:In Vitro and In Vivo Experimental Model-based Approaches for Investigating Anti-inflammatory Properties of Coumarins
Volume: 25 Issue: 12
关键词: 抗炎作用,香豆素,体内,体外,水肿,介质,转录因子。
摘要: Background: Coumarins are polyphenolic compounds that are often used to treat inflammatory conditions in complementary and alternative medicine.
Objective: In this study, we reviewed reports of in vivo and in vitro experimental modelbased approaches investigating the potential anti-inflammatory properties of coumarins.
Methods: A literature search of PUBMED, MEDLINE, Web of Science, and Scopus was performed covering the period from 1 January 2005 to 31 December 2015. The keywords used to search were ‘anti-inflammatory' and ‘coumarin' and ‘in vivo' or ‘in vitro'. This search identified 425 article titles.
Results: Of the 425 article titles, 127 full-text articles were reviewed, and 69 of them were included in the analysis. Most of the studies (81.2%) used in vitro assays. The studies focused on cytokines such as tumour necrosis factor (TNF), interleukin (IL)-6, and IL-1-β (55.1%), as well as oedema (46.5%), nitric oxide (NO, 23.2%), oxidative stress (21.7%), inflammatory cells (21.7%), nuclear factor (NF)-κB (24.6%), mitogen-activated protein kinase (MAPK, 13%), myeloperoxidase (MPO, (15.9%), cyclooxygenase (COX)-2 (14.5%), prostaglandin E2 (PGE2, 8.7%), 5-lipoxygenase (LOX, 4.3%), and adhesion molecules (7.2%). Coumarins inhibited all these parameters except for IL-10, nuclear factor erythroid 2 (NFE2)-related-factor 2 (Nrf2), and regulatory T cell (Treg) differentiation.
Conclusion: In vitro methods were the most commonly used to study the antiinflammatory effects of coumarins. The results showed that coumarins exerted antiinflammatory and antioxidant activities by inhibiting NF-κB, nuclear factor of activated T cells (NFAT), retinoic acid-related orphan receptor γτ (RORγτ), and MAPK and increasing Nrf2 activation. These results suggest that coumarins could be important candidates for the development of novel anti-inflammatory therapeutic drugs.
Export Options
About this article
Cite this article as:
In Vitro and In Vivo Experimental Model-based Approaches for Investigating Anti-inflammatory Properties of Coumarins, Current Medicinal Chemistry 2018; 25 (12) . https://dx.doi.org/10.2174/0929867324666170502122740
DOI https://dx.doi.org/10.2174/0929867324666170502122740 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Advances in the Molecular Detection of ABC Transporters Involved in Multidrug Resistance in Cancer
Current Pharmaceutical Biotechnology The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
Current Cancer Drug Targets Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders
Current Stem Cell Research & Therapy Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Functional Consequences of Immune Cell Adhesion to Endothelial Cells
Current Pharmaceutical Design Editorial [Hot Topic: Mechanisms of Drug Sensitivity and Resistance in Cancer (Guest Editor: Lorraine ODriscoll)]
Current Cancer Drug Targets Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Angiotensin Peptides and Lung Cancer
Current Cancer Drug Targets Folate-conjugated Chitosan-poly(ethylenimine) Copolymer As An Efficient and Safe Vector For Gene Delivery in Cancer Cells
Current Gene Therapy Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An <i>In Silico</i> Approach
Current Cancer Drug Targets Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics
Current Cancer Drug Targets Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Current Stem Cell Research & Therapy Heat Shock Protein 90 Inhibitors in Oncology
Current Proteomics Retrospective Observational Study to Evaluate Causality, Preventability and Severity of Adverse Drug Reaction Associated with Anticancer Drugs in a Tertiary Care Hospital in Northern India
Current Drug Safety Cellular Targets for Anticancer Strategies
Current Drug Targets